BridgeMD
Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
EU CTIS ID: 2024-516255-41-00
What this study is testing
Compare the incidence of albumin-corrected hypocalcaemia (blood calcium less than 2 mmol/L, a sign associated with hypoparathyroidism) postoperatively between the group using indocyanine green and the group not using indocyanine green.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients requiring total thyroidectomy
- Signed consent
- Patient covered by a social security scheme
You likely can't join if
- Patients under 18 years of age
- Protected adult or person incapable of giving consent to the study
- Pregnant and breast-feeding women
- Total thyroidectomy (removal of the remaining thyroid lobe in a patient who has already had a hemi thyroidectomy)
- Previous thyroid or parathyroid surgery
- Refusal to participate
See the full eligibility criteria
- Patients requiring total thyroidectomy
- Signed consent
- Patient covered by a social security scheme
- Patients under 18 years of age
- Protected adult or person incapable of giving consent to the study
- Pregnant and breast-feeding women
- Total thyroidectomy (removal of the remaining thyroid lobe in a patient who has already had a hemi thyroidectomy)
- Previous thyroid or parathyroid surgery
- Refusal to participate
- Known allergic reaction to indocyanine green (ICG)
- Women of childbearing age not using an adequate method of contraception
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.